An update on the measurement of productivity losses due to rheumatoid diseases

Best Practice and Research: Clinical Rheumatology

Volumn 26, Issue 5, 2012, Pages 585-597

  Zhang, Wei ^a,b   Chiu, Judy A ^a   Bansback, Nick ^a,b   Anis, Aslam H ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cost effectiveness; Policy; Productivity; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; METHOTREXATE;

ABSENTEEISM; ALGORITHM; BUDGET; CHILD CARE; CLINICAL DECISION MAKING; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; LEISURE; PHARMACOECONOMICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMUNERATION; REVIEW; RHEUMATIC DISEASE; SHOPPING; SOCIAL WELFARE; UNEMPLOYMENT;

ARTHRITIS, RHEUMATOID; COST OF ILLNESS; EFFICIENCY; GUIDELINES AS TOPIC; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84870492735     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2012.08.008     Document Type: Review

References (40)

1. The Arthritis Alliance of Canada. The impact of arthritis in Canada: today and over the next 30 Years. October 27, 2011. Available at: http://www.arthritisalliance.ca/docs/20111022-2200-impact-of-arthritis.pdf. Accessed July 17, 2012.
2. CDC National and state medical expenditures and lost earnings attributable to arthritis and other rheumatic conditions - United States, 2003 MMWR 56 2007 4 7
3. National Audit Office Services for people with rheumatoid arthritis Report by the comptroller and auditor general, HC 823 session 2008-2009 2009 National Audit Office 15 July 2009
4. X. Li, M.A.M. Gignac, and A.H. Anis The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work Medical Care 44 4 2006 304 310
5. W. Zhang, M.A.M. Gignac, D. Beaton, K. Tang, A.H. Anis, and on behalf of the Canadian Arthritis Network Work Productivity Group Productivity loss due to presenteeism among patients with arthritis: estimates from 4 instruments Journal of Rheumatology 2010
6. C.A. Marra, J.M. Esdaile, D. Guh, J.A. Kopec, J.E. Brazier, and B.E. Koehler A comparison of four indirect methods of assessing utility values in rheumatoid arthritis Medical Care 42 11 2004 1125 1131
7. W. Zhang, N. Bansback, and A.H. Anis Measuring and valuing productivity loss due to poor health: a critical review Social Science & Medicine 2011
8. M.F. Drummond, M.J. Sculpher, G.W. Torrance, B.J. O'Brien, and G.L. Stoddart Methods for the economic evaluation of health care programmes 3rd ed. 2005 Oxford university press New York
9. M. Johannesson The willingness to pay for health changes, the human-capital approach and the external costs Health Policy 36 3 1996 231 244
10. M.A. Koopmanschap, F.F. Rutten, B.M. van Ineveld, and L. van Roijen The friction cost method for measuring indirect costs of disease Journal of Health Economics 14 2 1995 171 189
11. M. Johannesson, and D. Melzer Some reflections on cost-effectiveness analysis Health Economics 7 1998 1 7
12. M. Johannesson, and G. Karlsson The friction cost method: a comment Journal of Health Economics 16 2 1997 249 255 discussion 257-9
13. M.V. Pauly, S. Nicholson, J. Xu, D. Polsky, and P.M. Danzon A general model of the impact of absenteeism on employers and employees Health Economics 11 2002 221 231
14. M.E. Gold, J.E. Siegel, L.B. Russell, and M.C. Weinstein Cost-effectiveness in health and medicine 1996 Oxford University Press Oxford and New York
15. M.C. Weinstein, J.E. Siegel, A.M. Garber, J. Lipscomb, B.R. Luce, and W.G. Manning Jr. Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group Health Economics 6 1997 505 510
16. W.B.F. Brouwer, M.A. Koopmanschap, and F.F.H. Rutten Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel Health Economics 6 1997 253 259
17. W.B.F. Brouwer, M.A. Koopmanschap, and F.F.H. Rutten Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion Health Economics 6 1997 511 514
18. Nyman JA. (2010). Productivity costs revisited: toward a new US policy. Article first published online: 6 OCT 2011. DOI:10.1002/hec.1795.
19. J.A. Singh, G.A. Wells, R. Christensen, E. Tanjong Ghogomu, L. Maxwell, and J.K. Macdonald Adverse effects of biologics: a network meta-analysis and Cochrane overview Cochrane Database of Systematic Reviews 2 2011 CD008794
20. J.A. Singh, R. Christensen, G.A. Wells, M.E. Suarez-Almazor, R. Buchbinder, and M.A. Lopez-Olivo A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview Canadian Medical Association Journal 181 11 2009 787 796
21. M.C. Reilly, A.S. Zbrozek, and E.M. Dukes The validity and reproducibility of a work productivity and activity impairment instrument Pharmacoeconomics 4 1993 353 365
22. J.T. Osterhaus, O. Purcaru, and L. Richard Discriminant validity, responsiveness and reliability of the rheumatoid arthritis-specific Work Productivity Survey (WPS-RA) Arthritis Research & Therapy 11 3 2009 R73
23. G. Gilworth, M.A. Chamberlain, A. Harvey, A. Woodhouse, J. Smith, and M.G. Smyth Development of a work instability scale for rheumatoid arthritis Arthritis & Rheumatism 49 3 2003 349 354
24. W. Zhang, and A.H. Anis The economic burden of rheumatoid arthritis: beyond health care costs Clinical Rheumatology 30 Suppl 1 2011 S25 S32
25. V. Bejarano, M. Quinn, P.G. Conaghan, R. Reece, A.M. Keenan, and D. Walker Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis Arthritis & Rheumatism 59 10 2008 1467 1474
26. W.B. Van den Hout, Y.P.M. Goekoop-Ruiterman, C.F. Allaart, J.K. de Vries-Bouwstra, J.M.M. Hazes, and P.J.S.M. Kerstens Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis Arthritis & Rheumatism 61 3 2009 291 299
27. A. Anis, W. Zhang, P. Emery, H. Sun, A. Singh, and B. Freundlich The effect of etanercept on work productivity in patients with early active rheumatoid arthritis: results from the COMET Study Rheumatology 48 2009 1283 1289
28. M. Johannesson, B. Jonsson, L. Jonsson, G. Kobelt, and N. Zethraeus Why should economic evaluations of medical innovations have a societal perspective? 2009 Office of Health Economics London
29. B. Jonsson Ten arguments for a societal perspective in the economic evaluation of medical innovations The European Journal of Health Economics 10 4 2009 357 359
30. Black DC. (2008). Working for a healthier tomorrow - Dame Carol Black's review of the health of Britain's working age population. Available at: http://www.dwp.gov.uk/docs/hwwb-working-for-a-healthier-tomorrow.pdf. Accessed July 17, 2012.
31. W. Zhang, N. Bansback, A. Boonen, J.L. Severens, and A.H. Anis Development of a composite questionnaire, the valuation of lost productivity (VOLP), to value productivity losses: application in rheumatoid arthritis Value in Health 15 1 2012 46 54
32. W. Zhang, N. Bansback, J. Kopec, and A. Anis Measuring time input loss among patients with rheumatoid arthritis: validity and reliability of the valuation of lost productivity questionnaire Journal of Occupational and Environmental Medicine 53 2011 530 536
33. J.B. Wong, G. Singh, and A. Kavanaugh Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis American Journal of Medicine 113 2002 400 408
34. J.S. Smolen, C. Han, D. van der Heijde, P. Emery, J.M. Bathon, and E. Keystone Infliximab treatment maintains employability in patients with early rheumatoid arthritis Arthritis & Rheumatism 54 3 2006 716 722
35. J.C. Cole, T. Li, P. Lin, R. MacLean, and G.V. Wallenstein Treatment impact on estimated medical expenditure and job loss likelihood in rheumatoid arthritis: re-examining quality of life outcomes from a randomized placebo-controlled clinical trial with abatacept Rheumatology 47 2008 1044 1050
36. G.A. Wells, T. Li, L. Maxwell, R. Maclean, and P. Tugwell Responsiveness of patient reported outcomes including fatigue, sleep quality and activity limitation and quality of life following treatment with abatacept in patients with rheumatoid arthritis Annals of the Rheumatic Diseases 67 2 2008 620 625
37. A.L. Hassett, T. Li, S. Buyske, S.V. Savage, and M.A.M. Gignac The multi-faceted assessment of independence in patients with rheumatoid arthritis: preliminary validation from the ATTAIN study Current Medical Research & Opinion 24 5 2008 1443 1453
38. W.N. Burton, A. Morrison, Y. Yuan, T. Li, R.E. Marioni, and R. Maclean Productivity cost model of the treatment of rheumatoid arthritis with abatacept Journal of Medical Economics 11 1 2008 3 21
39. A. Kavanaugh, J. Smolen, P. Emery, O. Purcaru, E. Keystone, and V. Strand Effect of certolizumab pegol with methotrexate on home and workplace productivity and social activities in patients with active rheumatoid arthritis Arthritis Care & Research 61 11 2009 1592 1600
40. R.F. van Vollenhoven, M.A. Cifaldi, S. Ray, N. Chen, and M.H. Weisman Improvement of work place and household productivity for patients with early rheumatoid arthritis treated with adalimumab plus methotrexate: work outcomes and their correlations with clinical and radiographic measures from a randomized controlled trial companion study Arthritis Care & Research 62 2 2010 226 234